The Role of PDE5-Inhibitors in Cardiopulmonary Disorders: From Basic Evidence to Clinical Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|20|2181-2192

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.20, 2007-08, pp. : 2181-2192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE-5 Inhibitors: Clinical Points

By  

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 420-426

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 Inhibitors and their Applications

By  

Current Medicinal Chemistry, Vol. 17, Iss. 24, 2010-08 ,pp. : 2564-2587

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 Inhibitors in the Treatment of LUTS

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3502-3505

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical Development

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 366-376

Bentham Science Publishers

Access to resources Recommend Favorite

Is There a Role for PDE5 Inhibitors in the Management of Male Infertility Due to Defects in Testicular or Epididymal Function?

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3506-3520

Bentham Science Publishers

Access to resources Recommend Favorite